CWIV-053

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCWIV-053
Drug Alias NameLG-100268 pyrimidine derivatives (Michigan State University/Dartmouth Medical School/Arizona State University)CWIV-053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor modulators
TargetsRetinoid X receptor
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMichigan State University
China Registration ClassN/A

Develop Information

Active CompaniesGeisel School Of MedicineMichigan State UniversityArizona State University
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A